NEUROLOGY

Lentiviral Vectors for Gene Delivery to the Nervous System

Sep 24, 2016 by in NEUROLOGY Comments Off on Lentiviral Vectors for Gene Delivery to the Nervous System

Pseudotype envelope Tropism and other features References Amphotropic MLV Efficient transduction of hematopoietic progenitor cells, T lymphocytes Reviewed in [60] Aura virus Transduction of monocyte derived dendritic cells (DCs), useful…

read more

Gene Therapy for Epilepsies

Sep 24, 2016 by in NEUROLOGY Comments Off on Gene Therapy for Epilepsies

Target gene Injection region Vector Experimental model Functional outcome References GAD Substantia nigra Engineered cells overexpressing GAD65 Kindling Increased seizure threshold Thompson et al. [66]  Substantia nigra Engineered cells overexpressing…

read more

Gene Therapy for Huntington’s Disease

Sep 24, 2016 by in NEUROLOGY Comments Off on Gene Therapy for Huntington’s Disease

Volume Reagent Final concentration Complete DMEM media 500 mL DMEM (Invitrogen #12430-062)  50 mL Fetal bovine serum (Thermo HyClone #SH30406.02) 9 % 5 mL Non-essential amino acids (100×, Invitrogen, #11140050)…

read more

Gene Delivery and Gene Therapy for Alzheimer’s Disease

Sep 24, 2016 by in NEUROLOGY Comments Off on Gene Delivery and Gene Therapy for Alzheimer’s Disease

Serotype Natural host/origin Optimal organ/tissue/cell type transduced CNS area transduced Receptor Coreceptor Blood–brain barrier penetration Disease targets AAV1 Monkey Muscle [39], Liver [110], CNS [32, 42] SNpc, SNpr, midbrain, hippocampus…

read more

Targeted Gene Therapy for Ischemic Stroke

Sep 24, 2016 by in NEUROLOGY Comments Off on Targeted Gene Therapy for Ischemic Stroke

Fig. 1 (a) Nine copies of Epo HRE consensus sequence. The HIF-1 binding sites are underlined. (b) Schematic drawing of H9LacZ and H9VEGF. Nine copies of Epo HRE (9HRE) were…

read more

Gene Therapy Approaches Using Reproducible and Fully Penetrant Lentivirus-Mediated Endogenous Glioma Models

Sep 24, 2016 by in NEUROLOGY Comments Off on Gene Therapy Approaches Using Reproducible and Fully Penetrant Lentivirus-Mediated Endogenous Glioma Models

Author (reference) Animal System Age/injection site Proliferation (RTK/KRAS/PI3K) Apoptosis (p53/ARF) Cell cycle (Rb/INK4) Best combined penetrance Holland et al. 2000 [13] Mice RCAS Neonatal/R frontal AKT, KRAS   26 % Dai…

read more
Get Clinical Tree app for offline access